Cell Biotech Developing World’s First Microbiome-Based Colorectal Cancer Drug

(Source = Sangsang Certificate) Certified Sangsang announced on the 21st that Cell Biotech is developing the world’s first new microbiome-based colorectal cancer drug (PP-P8) and expects clinical approval from the Ministry of Food and Drug Safety. Lee Jong-won, a researcher at Sangsang Certificate, said: “Cell Biotech is developing a gene therapy by injecting the P8 […]
The post Cell Biotech Developing World’s First Microbiome-Based Colorectal Cancer Drug appeared first on News Directory 3.